Testis expressed 50 is essential for maintaining sperm acrosome integrity during epididymal transit

S Saori Haga (Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center) K Kaori Nozawa (Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center) F Ferheen Abbasi (Research Institute for Microbial Diseases, Department of Experimental Genome Research, The University of Osaka) K Katarzyna Kent (Center for Drug Discovery, Department of Pathology and Immunology, Baylor College of Medicine) N Naoko Nagasawa (Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center) T Tsutomu Endo (Graduate School of Agricultural and Life Sciences, Department of Animal Resource Sciences, The University of Tokyo) H Haruhiko Miyata (Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka) M Masahito Ikawa (Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka) M Martin M. Matzuk (Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine) Y Yoshitaka Fujihara (Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center)

Abstract

In mammals, sperm formation is completed in the seminiferous tubules within the testis, and sperm maturation occurs during the epididymal transit of the spermatozoa. Sperm morphology drastically changes when abnormal spermatozoa migrate from the testis to the epididymis. Detailed molecular mechanisms for sperm survival in the epididymis have not been determined yet. Globozoospermia is a cause of male infertility and is characterized by round-headed spermatozoa without acrosomes, an abnormal sperm nuclear membrane, and sperm midpiece defects. Testis expressed 50 ( Tex50 ) is a testis-enriched gene that is expressed in mice and humans. Using CRISPR-Cas9, we generated Tex50 knockout (KO) mice and found that the KO males were sterile due to epididymal sperm malformations and impaired sperm motility. Surprisingly, electron microscopy, sperm morphology, and globozoospermia-related protein expression and localization in the KO testis were all normal. To understand this phenotype in more detail, we created TEX50-mCherry knockin mice to determine the localization of the TEX50 protein during spermatogenesis. The mCherry signals detected a ring-shaped structure surrounding the sperm acrosome and migrated to the posterior region of the sperm head. After the acrosome reaction, most of the spermatozoa retained mCherry signals. These results indicate that the Tex50 KO globozoospermia phenotype occurs after the migration of spermatozoa from the testis to the epididymis. We found that sperm membrane protein TEX50 is a putative key molecule to survive against globozoospermia-like malformations in the epididymis. It is essential for complete sperm formation and male fertility in mice.

Article Details

Volume / Issue Vol. 122, Issue 36
Published September 09, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (10)

S

Saori Haga

Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center

K

Kaori Nozawa

Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center

F

Ferheen Abbasi

Research Institute for Microbial Diseases, Department of Experimental Genome Research, The University of Osaka

K

Katarzyna Kent

Center for Drug Discovery, Department of Pathology and Immunology, Baylor College of Medicine

N

Naoko Nagasawa

Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center

T

Tsutomu Endo

Graduate School of Agricultural and Life Sciences, Department of Animal Resource Sciences, The University of Tokyo

H

Haruhiko Miyata

Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka

M

Masahito Ikawa

Department of Experimental Genome Research, Research Institute for Microbial Diseases, The University of Osaka

M

Martin M. Matzuk

Center for Drug Discovery, Department of Pathology & Immunology, Baylor College of Medicine

Y

Yoshitaka Fujihara

Department of Advanced Medical Technologies, National Cerebral and Cardiovascular Center